Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers

Health

Head shaving big hit at lifestyle village Middlemore Hospital's emergency department reaches full capacity Two NZ batches in global EpiPen recall Protesters demand filters if council adds fluoride to water Crunch time for baby boomers as health insurance premiums sky-rocket Cromwell man with terminal cancer making family memories while he can IDEA Services plans to cut 5 per cent of its business, affecting more than 1000 service users Waikato Hospital on a recruitment drive for midwives Woman comes out of coma after doctors tell her mother to turn off life support In-utero anxiety from Christchurch earthquakes showing up at school

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?

Yes

No

Vote Result

Featured Promotions

Sponsored Content